- Global Pharma News & Resources

Press Releases - 2022-03-12

Date Title Company
12-Mar-2022 Femtech Market is estimated to hit a valuation of US$ 948.1 Mn in 2021, with a market CAGR of 15.0% during the forecast period 2021-2031 MARKITWIRED
12-Mar-2022 Electronic Stethoscope Market is expected to create an incremental opportunity worth US$ 170.9 Million between 2022 and 2029 MARKITWIRED
12-Mar-2022 Dosimetry Market with a CAGR of 6.8% which indicates a positive market growth over the forecast period 2022-2029 MARKITWIRED
12-Mar-2022 Dermal Fillers Market is anticipated to grow at a CAGR of 2.9% between 2021 and 2031 MARKITWIRED
12-Mar-2022 Cold Laser Therapy Market are set to reach US$ 165.4 Million by 2031 MARKITWIRED
12-Mar-2022 Cellulite Treatment Market is predicted to expand at an impressive CAGR of 7.8% to reach a valuation of US$ 5.2 Billion by 2028 MARKITWIRED
12-Mar-2022 Behavioural Health Market is expected to expand at 3.4% CAGR over the forecast period 2022-2028 MARKITWIRED
12-Mar-2022 Atopic Dermatitis Treatment Market is expected to grow at a CAGR of 12% during forecast period of 2019-2029 MARKITWIRED
12-Mar-2022 Allergy Immunotherapy Market will reach a valuation of US$ 2,892.2 Million by the end of 2030 MARKITWIRED
12-Mar-2022 3D Bioprinting Market is expected to grow at a Robust CAGR of 13% during the forecast period 2020-2030 MARKITWIRED
12-Mar-2022 FDA Approves LYNPARZA® (olaparib) as Adjuvant Treatment for Patients With Germline BRCA-Mutated (gBRCAm), HER2-Negative High-Risk Early Breast Cancer Who Have Been Treated With Neoadjuvant or Adjuvant Chemotherapy Businesswire